Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Markman

Showing results (21-30 of 545) with videos related to

Pageof 55
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapyM Markman
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Supportive careM Markman
Drugs|July 24, 2001
Intraperitoneal drug delivery of antineoplasticsM Markman
Current Oncology Reports|March 20, 2001
Cancer and the Internet: the good, the bad, and the very uglyM Markman
Hematology/Oncology Clinics of North America|September 1, 1988
Chemotherapy in ovarian carcinoma: intravenous or intraperitoneal?M Markman
The Yale Journal of Biology and Medicine|November 1, 1991
Taxol: an important new drug in the management of epithelial ovarian cancerM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
The difficulty defining "benefit" of new antineoplastic strategiesM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the Second National Cancer Institute Workshop on Taxol and Taxus. 23-24 September 1992M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1995
36th annual meeting of the American Society of Hematology. Nashville, 2-6 December 1994M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1995
26th annual meeting of the Society of Gynecologic Oncologists. San Francisco, 18-22 February 1995M Markman
Pageof 55

Showing results (21-30 of 545) with videos related to

Sort By:
Pageof 55
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2011
The use of bevacizumab in the management of ovarian cancer: an argument for single-agent rather than combination therapyM Markman
Cancer Chemotherapy and Biological Response Modifiers|May 9, 2000
Supportive careM Markman
Drugs|July 24, 2001
Intraperitoneal drug delivery of antineoplasticsM Markman
Current Oncology Reports|March 20, 2001
Cancer and the Internet: the good, the bad, and the very uglyM Markman
Hematology/Oncology Clinics of North America|September 1, 1988
Chemotherapy in ovarian carcinoma: intravenous or intraperitoneal?M Markman
The Yale Journal of Biology and Medicine|November 1, 1991
Taxol: an important new drug in the management of epithelial ovarian cancerM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
The difficulty defining "benefit" of new antineoplastic strategiesM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1993
Report from the Second National Cancer Institute Workshop on Taxol and Taxus. 23-24 September 1992M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1995
36th annual meeting of the American Society of Hematology. Nashville, 2-6 December 1994M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1995
26th annual meeting of the Society of Gynecologic Oncologists. San Francisco, 18-22 February 1995M Markman
Pageof 55